The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus.
Open accessAbstract
Family and population studies indicate that predisposition to insulin-dependent (type I) diabetes mellitus (IDDM) is polygenic. It has been shown that the absence of the aspartic acid in position 57 (Asp57) of the DQ beta chain is positively correlated to IDDM. However, Asp57-negative haplotypes do not always confer susceptibility and conversely, some Asp57-positive haplotypes seem to be disease associated. It has been suggested that other HLA class II sequences, probably belonging to the HLA DQA1 gene, confer susceptibility to IDDM. This report, based on extensive oligonucleotide dot blot hybridization of PCR-amplified DQA1 and DQB1 genes, reinforces the importance of the Asp57-negative DQ beta chain, but also introduces the possibility that a DQ alpha chain bearing an arginine in position 52 (Arg52) confers susceptibility to IDDM. A molecular model of susceptibility to IDDM is proposed. This model strongly suggests that the disease susceptibility correlates quantitatively with the expression at the cell surface of a heterodimer, composed of a DQ alpha-chain bearing an Arg52 and a DQ beta chain lacking an Asp57. In view of the respective positions of the two residues and their charge, we might anticipate that both residues DQ beta Asp57 and DQ alpha Arg52 are critical for modulation of susceptibility, presumably via viral-antigenic peptide and/or autoantigen presentation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure of the human class I histocompatibility antigen, HLA-A2
Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., & Wiley, D. C. (1987) · Nature · doi:10.1038/329506a0 · Cited by 3,472
Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., & Wiley, D. C. (1987) · Nature · doi:10.1038/329512a0 · Cited by 2,377
HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus
Todd, J. A., Bell, J. I., & McDevitt, H. O. (1987) · Nature · doi:10.1038/329599a0 · Cited by 2,036
Saiki, R. K., Bugawan, T. L., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1986) · Nature · doi:10.1038/324163a0 · Cited by 1,827
A hypothetical model of the foreign antigen binding site of Class II histocompatibility molecules
Brown, J. H., Jardetzky, T., Saper, M. A., Samraoui, B., Bjorkman, P. J., & Wiley, D. C. (1988) · Nature · doi:10.1038/332845a0 · Cited by 1,147
Horn, G. T., Bugawan, T. L., Long, C. M., & Erlich, H. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.6012 · Cited by 377
Sette, A., Buus, S., Colon, S., Smith, J. A., Miles, C., & Grey, H. M. (1987) · Nature · doi:10.1038/328395a0 · Cited by 364
Wolf, E., Spencer, K. M., & Cudworth, A. G. (1983) · Diabetologia · doi:10.1007/bf00282704 · Cited by 248
Genetic Complexity and Expression of Human Class II Histocompatibility Antigens
Korman, A. J., Boss, J. M., Spies, T., Sorrentino, R., Okada, K., & Strominger, J. L. (1985) · Immunological Reviews · doi:10.1111/j.1600-065x.1985.tb01130.x · Cited by 241
Todd, J. A., Mijovic, C., Fletcher, J., Jenkins, D., Bradwell, A. R., & Barnett, A. H. (1989) · Nature · doi:10.1038/338587a0 · Cited by 237
The significance of the concordance rate for Type 1 (insulin-dependent) diabetes in identical twins
Olmos, P., A'Hern, R., Heaton, D. A., Millward, B. A., Risley, D., Pyke, D. A., & Leslie, R. D. G. (1988) · Diabetologia · doi:10.1007/bf00274777 · Cited by 220
Nepom, B. S., Schwarz, D. A., Palmer, J. P., & Nepom, G. T. (1987) · Diabetes · doi:10.2337/diab.36.1.114 · Cited by 154
Michelsen, B. K., & Lernmark, Å. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112931 · Cited by 110
Johnston, C., Pyke, D. A., Cudworth, A. G., & Wolf, E. (1983) · BMJ · doi:10.1136/bmj.286.6361.253 · Cited by 91
Nomenclature for Factors of the HLA System, 1990
Bodmer, J. G., Marsh, S. G. E., Albert, E. D., Bodtner, W. E., Dupont, B., Erlich, H. A., Mach, B., Mayr, W. R., Parham, P., Sasazuki, T., et al. (1991) · Vox Sanguinis · doi:10.1111/j.1423-0410.1991.tb00265.x · Cited by 50
Owerbach, D., Gunn, S., Ty, G., Wible, L., & Gabbay, K. H. (1988) · Diabetologia · doi:10.1007/bf00274778 · Cited by 32
HLA antigens and insulin-dependent diabetes
Todd, J. A., Bell, J. I., & McDevitt, H. O. (1988) · Nature · doi:10.1038/333710a0 · Cited by 31
The HLA-DQB1 Gene Contributes to the Genetic Susceptibility to Insulin-Dependent Diabetes Mellitus
Todd, J. A., Bell, J. I., & McDevitt, H. O. (1989) · Springer eBooks · doi:10.1007/978-3-662-39946-0_157 · Cited by 2
Cited by
MHC ligands and peptide motifs: first listing
Rammensee, H.-G., Friede, T., & Stevanović, S. (1995) · Immunogenetics · doi:10.1007/bf00172063 · Cited by 1,638
HLA class II‐associated genetic susceptibility in multiple sclerosis: A critical evaluation
Olerup, O., & Hillert, J. (1991) · Tissue Antigens · doi:10.1111/j.1399-0039.1991.tb02029.x · Cited by 490
Susceptibility to type I diabetes: HLA-DQ and DR revisited
she, J.-X. (1996) · Immunology Today · doi:10.1016/0167-5699(96)10014-1 · Cited by 320
Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus.
Caillat-Zucman, S., Garchon, H. J., Timsit, J., Assan, R., Boitard, C., Djilali-Saiah, I., Bougnères, P., & Bach, J. F. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116110 · Cited by 289
On type 1 diabetes mellitus pathogenesis
Paschou, S. A., Papadopoulou-Marketou, N., Chrousos, G. P., & Kanaka-Gantenbein, C. (2018) · Endocrine Connections · doi:10.1530/ec-17-0347 · Cited by 260
Metadata
- Authors
- Khalil, I., d'Auriol, L., Gobet, M., Morin, L., Lepage, V, Deschamps, I., Park, M. S., Degos, L., Galibert, F., & Hors, J.
- Venue
- Journal of Clinical Investigation
- Published
- 1990-04-01
- Volume
- 85
- Issue
- 4
- Pages
- 1315-1319
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2099000356
- Cited by
- 330
- References
- 18
- FWCI
- 24.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.